IA therapy of HCC with CSR02-Fab-TF Clinical Trials

1 actively recruiting trial

No change since May 2026

Pipeline

Early 1: 1

Top Sponsors

Koo Foundation Sun Yat-Sen Cancer Center1

Indications

Liver Disease1
Hepatocellular Carcinoma (HCC)1
Liver Cancer1
Cancer1

Other1 trial

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.